Trial
NCT01702792
Derivation of Tumor Specific Hybridomas
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
University of Vermont
Condition
Glioblastoma
Intervention
Tumor Vaccine
Why stopped
Investigator is leaving Dartmouth
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-04